Aeternum Health (AETN) Return on Sales (2010 - 2026)

Aeternum Health (AETN) has 12 years of Return on Sales data on file, last reported at 0.62% in Q1 2026.

• Return on Sales for Q1 2026 came in at 0.62%, down 62.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.12% (down 10.0% YoY), and the FY2025 annual result was 0.02%, up 6.0% from the prior year.
• Return on Sales eased to 0.62% in Q1 2026 per AETN's latest filing, from 0.04% in the prior quarter.
• Over five years, Return on Sales peaked at 0.0% in Q1 2025 and troughed at 1.23% in Q3 2023.
• A 5-year average of 0.23% and a median of 0.11% in 2023 frame the typical range for Return on Sales.
• On a YoY basis, Return on Sales climbed as much as 7 bps in 2023 and fell as far as 115 bps in 2023.
• A 5-year view of Return on Sales shows it stood at 0.06% in 2022, then tumbled by 508 bps to 0.36% in 2023, then soared by 69 bps to 0.11% in 2024, then soared by 63 bps to 0.04% in 2025, then slumped by 1365 bps to 0.62% in 2026.
• Business Quant data shows AETN's Return on Sales at 0.62% in Q1 2026, 0.04% in Q4 2025, and 0.17% in Q3 2025.